MERCK Press Releases http://www.thailand4.com/merck/ Merck and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer Merck and Pfizer Inc. (NYSE: PFE) today announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study of avelumab* did not support the study's initial hypothesis, and therefore the alliance made the decision to terminate th-TH Tue, 22 Jan 2019 21:58:08 +0700 Merck Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon http://www.thailand4.com/.food/2018-12-21/7b667f3530b1fb85a63e1ecb9c8ff562/ - Agreement enables Merck to maintain an investment in the rapidly advancing oncology field of CAR-T, while focusing its RD efforts - Intrexon to issue Merck $150 million of Intrexon stock and a $25 million convertible Intrexon to receive a http://www.thailand4.com/.food/2018-12-21/7b667f3530b1fb85a63e1ecb9c8ff562/ Fri, 21 Dec 2018 8:28:21 +0700 เมอร์ค และ genOway จับมือเป็นพันธมิตรทางธุรกิจ มุ่งสร้างโมเดลหนูทดลองรองรับเทคโนโลยี CRISPR/Cas9 http://www.thailand4.com/it/2018-12-11/bc8f675102286357c5323d67442b30b2/ - genOway จะได้รับสิทธิแต่เพียงผู้เดียวสำหรับสิทธิบัตรการปรับแต่งจีโนมของเมอร์ค เพื่อผลิตและจำหน่ายโมเดลหนูทดลอง - จะมีการพัฒนาเทคโนโลยีและโซลูชั่นใหม่ ๆ โดยใช้ CRISPR/Cas9 เพื่อเร่งการส่งมอบยาที่มีคุณภาพดียิ่งขึ้นให้กับคนไข้ เมอร์ค (Merck) http://www.thailand4.com/it/2018-12-11/bc8f675102286357c5323d67442b30b2/ Tue, 11 Dec 2018 16:39:28 +0700 Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models http://www.thailand4.com/.it/2018-12-11/3c78f7f487d5c01e2525325332fb5130/ - genOway to acquire exclusive rights to Merck#s foundational genome-editing patents to produce, sell rodent models - New technologies and solutions to be developed using CRISPR/Cas9 to accelerate delivery of better drugs to patients Merck, a leading http://www.thailand4.com/.it/2018-12-11/3c78f7f487d5c01e2525325332fb5130/ Tue, 11 Dec 2018 16:39:26 +0700 Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer http://www.thailand4.com/.food/2018-12-11/0875b2bacaf3f1d9e3373ddec42a9a51/ - FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive http://www.thailand4.com/.food/2018-12-11/0875b2bacaf3f1d9e3373ddec42a9a51/ Tue, 11 Dec 2018 8:00:25 +0700 Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities http://www.thailand4.com/.food/2018-12-07/d866485f3d5890c1a24d48c85f5d6d3f/ - Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include http://www.thailand4.com/.food/2018-12-07/d866485f3d5890c1a24d48c85f5d6d3f/ Fri, 07 Dec 2018 11:25:57 +0700 Merck Wins Two RD 100 Awards for Innovation in 2018 http://www.thailand4.com/.it/2018-11-28/d37ce55a709ac2efd13df4b0de1109d7/ - BioReliance(R) Viral and Gene Therapy Assay Portfolio wins award in Analytical/Test category - Merck#s proxy-CRISPR wins Special Recognition Market Disruptor Products award Merck, a leading science and technology company, today announced that http://www.thailand4.com/.it/2018-11-28/d37ce55a709ac2efd13df4b0de1109d7/ Wed, 28 Nov 2018 8:00:00 +0700 เมอร์ค คว้า 2 รางวัลจากเวที RD 100 Awards เชิดชูสุดยอดนวัตกรรมแห่งปี 2561 http://www.thailand4.com/it/2018-11-28/d490cfd4494bf55bdbd725f234c36652/ - นวัตกรรม proxy-CRISPR ของเมอร์ค คว้ารางวัล Special Recognition Market Disruptor Products เมอร์ค (Merck) บริษัทวิทยาศาสตร์และเทคโนโลยีชั้นนำ ได้ประกาศในวันนี้ว่า ทางบริษัทได้คว้า 2 รางวัลจากเวที RD 100 Awards ครั้งที่ 56 http://www.thailand4.com/it/2018-11-28/d490cfd4494bf55bdbd725f234c36652/ Wed, 28 Nov 2018 8:00:00 +0700 Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer http://www.thailand4.com/.food/2018-11-20/57a4eeb5824d7ec4c3c4d5dc4caa228f/ Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the http://www.thailand4.com/.food/2018-11-20/57a4eeb5824d7ec4c3c4d5dc4caa228f/ Tue, 20 Nov 2018 8:00:00 +0700 Merck Launches BioContinuum(TM) Platform for Next-Generation Process Improvements http://www.thailand4.com/.food/2018-11-06/bfbcd9ddf56cb2e25dedbb26f1c38bbe/ - New BioContinuum(TM) Platform provides benefits now, with a mind to continuous process of the future - Expanded Pellicon(R) Single-Pass Tangential Flow Filtration to intensify operations in the purification of therapeutic proteins Merck, the vibrant http://www.thailand4.com/.food/2018-11-06/bfbcd9ddf56cb2e25dedbb26f1c38bbe/ Tue, 06 Nov 2018 8:00:00 +0700 เมอร์ค เปิดตัวแพลตฟอร์ม BioContinuum(TM) มุ่งยกระดับศักยภาพกระบวนการผลิต http://www.thailand4.com/food/2018-11-06/ffbccf1a07190de65c97b3ebe09ee058/ - แพลตฟอร์มใหม่ BioContinuum(TM) พร้อมมอบประโยชน์แล้ววันนี้ รองรับกระบวนการผลิตแบบต่อเนื่องแห่งอนาคต - แอปพลิเคชันเสริม Pellicon(R) Single-Pass Tangential Flow Filtration ช่วยยกระดับกระบวนการทำโปรตีนเพื่อการรักษาให้บริสุทธิ์ เมอร์ค (Merck) http://www.thailand4.com/food/2018-11-06/ffbccf1a07190de65c97b3ebe09ee058/ Tue, 06 Nov 2018 8:00:00 +0700 Merck Presents Updated Results for Bifunctional Immunotherapy M7824 at ESMO 2018 Congress http://www.thailand4.com/.food/2018-10-24/69175622f74acd2fb5f8407a744fb5d5/ - New data presented at the ESMO 2018 Congress include first disclosure of results for M7824 in advanced squamous cell carcinoma of the head and neck, biliary tract cancer and esophageal cancers - Updated data also being presented include non-small cell http://www.thailand4.com/.food/2018-10-24/69175622f74acd2fb5f8407a744fb5d5/ Wed, 24 Oct 2018 10:05:47 +0700 เมอร์ค ประกาศข้อตกลงขายธุรกิจโฟลไซโทเมทรี Amnis(R) และ Guava(R) ให้แก่ Luminex Corporation http://www.thailand4.com/it/2018-10-19/5b927b1b82cd5c0120dcc0b50e19ab3d/ เมอร์ค (Merck) บริษัทวิทยาศาสตร์และเทคโนโลยีที่ไม่หยุดนิ่ง ประกาศลงนามข้อตกลงขั้นสุดท้ายในการขายธุรกิจ Flow Cytometry ให้แก่ Luminex Corporation เป็นมูลค่า 62.5 ล้านยูโร[1] สำหรับการปิดการทำธุรกรรมดังกล่าวจะขึ้นอยู่กับเงื่อนไขตามที่กำหนด http://www.thailand4.com/it/2018-10-19/5b927b1b82cd5c0120dcc0b50e19ab3d/ Fri, 19 Oct 2018 14:26:10 +0700 Merck Announces Agreement to Sell Amnis(R) Flow Cytometry and Guava(R) Technologies Businesses to Luminex Corporation http://www.thailand4.com/.it/2018-10-19/92544639a652a06d3f9d44b9440d2dae/ - Strategic agreement allows Luminex to increase footprint in multi-billion-dollar flow cytometry market - Deal expected to close at end of 2018 Merck, the vibrant science and technology company, today announced the signing of a definitive agreement to http://www.thailand4.com/.it/2018-10-19/92544639a652a06d3f9d44b9440d2dae/ Fri, 19 Oct 2018 14:26:08 +0700 Merck Inaugurates State-of-the-art Pharma Packaging Center in Darmstadt http://www.thailand4.com/.food/2018-10-18/facf232721f2761fc411efca847ee1fc/ - Expansion of the pharma manufacturing site at Merck#s headquarters supports growth of current and future portfolio of pharma medicines - New building dedicated to the packaging and shipping of Merck#s pharma medicines in more than 90 countries - EUR63 http://www.thailand4.com/.food/2018-10-18/facf232721f2761fc411efca847ee1fc/ Thu, 18 Oct 2018 8:10:55 +0700 Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis http://www.thailand4.com/.food/2018-10-12/cbba32c3dd990f61a552c5b9e22f3da9/ - Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved one with MS - #MSInsideOut documentary film, executively produced by Shift.ms, provides artistic take on the experiences of those http://www.thailand4.com/.food/2018-10-12/cbba32c3dd990f61a552c5b9e22f3da9/ Fri, 12 Oct 2018 8:35:46 +0700 Merck Data at ESMO 2018 Congress Highlight Multiple Therapeutics with Potential to Transform Cancer Care http://www.thailand4.com/.food/2018-10-09/182c4bcc8cbe1ad2e96188d2139aef8d/ Avelumab: LBA6_PR, 659P, 1290P, 1291P, 1282P, M7824 (TGF -trap/anti-PD-L1):1048O, 1463P, 1931P, 757P, 643P, 642P, tepotinib (MET kinase inhibitor): 1377O, 621PD, M6620: M3814: M7583: abituzumab: http://www.thailand4.com/.food/2018-10-09/182c4bcc8cbe1ad2e96188d2139aef8d/ Tue, 09 Oct 2018 13:00:35 +0700 Merck Opens M Lab(TM) Collaboration Center in Sao Paulo, Brazil http://www.thailand4.com/.food/2018-10-05/58908d727d97d61c199066eeba4ab4d5/ - New collaboration center to provide support from pre-clinical through full-scale production in a non-GMP environment - Hands-on customer access to Merck#s product portfolio, technical expertise Merck, the vibrant science and technology company, today http://www.thailand4.com/.food/2018-10-05/58908d727d97d61c199066eeba4ab4d5/ Fri, 05 Oct 2018 9:07:47 +0700 เมอร์ค เปิดศูนย์ความร่วมมือลูกค้า M Lab(TM) Collaboration Center ในเซาเปาโล ประเทศบราซิล http://www.thailand4.com/food/2018-10-05/bdc69d06d515bacc034cb8088aa4c273/ - ศูนย์ความร่วมมือแห่งใหม่จะให้การสนับสนุนลูกค้าตั้งแต่ขั้นตอนพรีคลินิกไปจนถึงการผลิตเต็มรูปแบบ ในสภาพแวดล้อมแบบ non-GMP - เปิดโอกาสให้ลูกค้าเข้าถึงผลิตภัณฑ์และความเชี่ยวชาญทางเทคนิคของเมอร์คได้โดยตรง เมอร์ค (Merck) http://www.thailand4.com/food/2018-10-05/bdc69d06d515bacc034cb8088aa4c273/ Fri, 05 Oct 2018 9:07:49 +0700 Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology http://www.thailand4.com/.food/2018-08-16/34024a94abc8ca6fe6143762bcf066b4/ - Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research - Expands company#s foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients - Merck to http://www.thailand4.com/.food/2018-08-16/34024a94abc8ca6fe6143762bcf066b4/ Thu, 16 Aug 2018 8:00:41 +0700 Merck Receives Recommendation for Approval in 21 EU Countries for the New Formulation of Euthyrox(R) http://www.thailand4.com/.food/2018-07-26/0784b5f8b28ee583dfdb87bbf063e227/ - German Federal Institute for Drugs and Medical Devices (BfArM) recommends new formulation of Euthyrox(R) for approval in 21 EU countries - BfArM is acting as a representative of all 21 EU countries involved in the EU worksharing procedure Merck, a http://www.thailand4.com/.food/2018-07-26/0784b5f8b28ee583dfdb87bbf063e227/ Thu, 26 Jul 2018 14:00:00 +0700 Merck Launches Online Platform Fertility.com http://www.thailand4.com/.food/2018-07-03/479eebaf0a91086bb2436bb0511f6138/ - Offering the latest scientific information to healthcare professionals in the advancing field of fertility - Supporting women, men and couples who are looking for information about fertility and/or undergoing fertility treatment (Photo: http://www.thailand4.com/.food/2018-07-03/479eebaf0a91086bb2436bb0511f6138/ Tue, 03 Jul 2018 15:15:56 +0700 Merck Launches Two New Technologies for Improved Efficiency in Fertility Labs http://www.thailand4.com/.food/2018-07-03/f8494ca8dac48c46bfebdc22c356437d/ - QBOX IVF streamlines data transfer between lab instruments and Electronic Medical Record providers - Geri(R) Assess 2.0 enables automatic detection of key events in embryo and blastocyst development, improving efficiencies in assessment - Merck http://www.thailand4.com/.food/2018-07-03/f8494ca8dac48c46bfebdc22c356437d/ Tue, 03 Jul 2018 8:12:15 +0700 Merck Drives Thought Leadership in Ethical Gene Editing http://www.thailand4.com/.it/2018-06-13/36b8207bfc7f13bbda7675004e727c9b/ - Co-authored publication, Ethical Considerations in the Manufacture, Sale and Distribution of Genome-Editing Technologies, accepted in leading bioethics journal - Highlights importance of science-based bioethics in genome editing and novel processes http://www.thailand4.com/.it/2018-06-13/36b8207bfc7f13bbda7675004e727c9b/ Wed, 13 Jun 2018 9:32:17 +0700 Merck Brings Biotechs Closer to Drug Therapy Production and Commercialization http://www.thailand4.com/.it/2018-06-06/7dc5a90415e37d83000df9cba0bfe123/ - Opens North America#s first BioReliance(R) End-to-End Biodevelopment Center to help customers with biopharmaceutical manufacturing processes - Accelerates clinical development from DNA to market - Advance Biotech Grant Program expands global http://www.thailand4.com/.it/2018-06-06/7dc5a90415e37d83000df9cba0bfe123/ Wed, 06 Jun 2018 8:37:33 +0700 Two Year Update of Pivotal JAVELIN Merkel 200 Trial Shows Continued Durable Responses with BAVENCIO(R) (avelumab) http://www.thailand4.com/.food/2018-06-05/85364bd819e7235f135f4c5b046d8e8d/ - Two-year follow-up data on meaningful durable response, overall survival (OS) and progression-free survival (PFS) to be presented in patients with metastatic Merkel cell carcinoma (mMCC), a rare and aggressive type of skin cancer Merck and Pfizer http://www.thailand4.com/.food/2018-06-05/85364bd819e7235f135f4c5b046d8e8d/ Tue, 05 Jun 2018 8:00:49 +0700 Merck Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO 2018 http://www.thailand4.com/.food/2018-06-05/a0355552fab4008099c8d913e0fc5f39/ M7824 (TGF-ss trap/anti-PD-L1): 3007, 9017, 2566, Tepotinib (c-Met kinase inhibitor): 9082, M2698 (dual p70S6k/Akt inhibitor): M6620 (ATR inhibitor): M3814 (DNA-PK): 2518 Not intended for UK- or US-based media - M7824 is an http://www.thailand4.com/.food/2018-06-05/a0355552fab4008099c8d913e0fc5f39/ Tue, 05 Jun 2018 8:00:38 +0700 Merck Presents Update on Tepotinib in Advanced Lung Cancer at ASCO 2018 http://www.thailand4.com/.food/2018-06-04/852d81fb89c626df5db3fb888f1047c4/ Tepotinib (c-Met kinase inhibitor): 9082, M7824 (TGF-ss trap/anti-PD-L1): 3007, 9017, M2698 (dual p70S6k/Akt inhibitor): M6620 (ATR inhibitor): M3814 (DNA-PK): 2518 Not intended for UK- or US-based media - Data from an ongoing http://www.thailand4.com/.food/2018-06-04/852d81fb89c626df5db3fb888f1047c4/ Mon, 04 Jun 2018 8:54:34 +0700 Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children http://www.thailand4.com/.food/2018-05-17/08f3be27a24b766f3f4e699056d2926d/ - Collaboration with Washington University on gut bacteria research could lead to diagnostics, treatment for malnourished children - Study to use Merck#s genome-editing technology Merck , a leading science and technology company and leader in genome http://www.thailand4.com/.food/2018-05-17/08f3be27a24b766f3f4e699056d2926d/ Thu, 17 May 2018 8:00:30 +0700 เมอร์ค ใช้เทคโนโลยีการปรับแต่งจีโนมในการศึกษาแบคทีเรียในลำไส้ เพื่อช่วยเหลือเด็กขาดสารอาหาร http://www.thailand4.com/food/2018-05-17/b2271f68863d4d8ed0c6bc1d37d5e472/ - ความร่วมมือกับมหาวิทยาลัยวอชิงตันเกี่ยวกับการวิจัยแบคทีเรียในลำไส้ อาจนำไปสู่การวินิจฉัยและรักษาเด็กที่ขาดสารอาหาร - การศึกษาดังกล่าวจะใช้เทคโนโลยีการปรับแต่งจีโนมของเมอร์ค เมอร์ค ( Merck ) บริษัทวิทยาศาสตร์และเทคโนโลยีชั้นแนวหน้า http://www.thailand4.com/food/2018-05-17/b2271f68863d4d8ed0c6bc1d37d5e472/ Thu, 17 May 2018 8:00:37 +0700